Диссертация (1139740), страница 17
Текст из файла (страница 17)
Sci., 2008.-Jun.- 50(2): - P. 123-129)166.Grahamef R. The hypermobilityf syndrome / R. Grahame // Annals of theRheumaticf diseases. – 1990. Vol. 49. – P. 199-200.167.Greene RM, Pisano MM. Perspectives on growth factors and orofacialdevelopment. Curr Pharm Des 2004; 10:2701-17.168.Grenbulen L.M. The incidencef of cleft lip and fcleft palate inf Nigeria/L.M. Grenbulen// Cleft Palate Sur. – 1982.-Vol. 19, № 3.
– P. 201 – 205.169.Habel fA. Management of cleft flip and palatef / A. Habel, D. Sell, M.Mars// Dis. Child. 1996. Vol. 74, №4. – P. 360-366.105170.Hidalgo M., Eckhardit G.S. Development f of Matrix MetalloproteinaseInhibitors in Cancer f Therapy. J. Nation. Cancer Inst. 2001; 93(3): 178-193(Close D.. Matrix metalloproteinase inhibitorsf in rheumatic diseases. Ann.Neum. Dis 2001; 60(3): 11162-11167.171.Hiller f O. Matrix metalloproteinases collagenase-2, macrophage f elastase,collagenase-3 and membrane f type 1-metrix metalloproteinase impair clotting bydegradation of fibrinogen and factor XII // J.
Biol. Chem. 2000. Vol. 275. P. 8-13.172.His fW. Die Entwicklung der f Menschlichen und f ThierischerPhysiognomen. // Arch f. Anat. Entwicklungsgesch S. – 1892. – P. 384.173.Hosokawa R, Nonaka K, Morifuji M, Shum L, Orishi M. TGF-β3 de-creases type I collagen and scarring after labioplasty. Journal of Dental Research2003; 82:7.174.Hwang B.F., Jaakkola J.J. Ozone and other air pollotants and the risk oforal clefts. //Envirion Health Perspect. 2008 Oct. – 116(10): - P.
1411-1415.175.Iozzo R.V., Proteoglycans f: structure, biology and molecular finteractions. New-York. Marcel fDekker Inc. 2000; 442.176.Iskandrian fA. Exercise left ventricular f performance in patients withfmitral valve fprolapse / A. Iskandrian // Herz. – 1988. - №13. – P. 243-348.177.Jocelyn L.J. Cognition, fcommunication and hearing in young f childrenwith cltft lip and palate and f in control children: a f longitudinal study / L.J.Jocelyn, M.A. Penko, H.L. Rode // Pediatrics. – 1996 – Vol. 97, №4. – P.
529534.178.Kaski J.C., Zouridakis E.G. Inflamation, f infection and acute coronaryplaque f events. Eur. Heart. J. 2001; 3(I):10-15.179.Kelly, fT. Teratogenicity fand anticonvulsant drug. f The assotiation ofclepting and epilepsy f / T. Kelly, fP P. EdwardsKlein, M. Rein // Ann. Y. Med.Genet. – 1984. – Vol. 19, № 8. – P. 451-458.180.Kleiner D.E., Stetler-Stevenson W.G.
Matrix metalloproteinases andmetastasis. Cancer Chemother Pharmacol. 1999; 43: 42-51.106181.Kourtzelis I. Complement anaphylatoxin fC5a contributes to hemodialysisf-associated thrombosis f / I. Kourtzelis [et al.] // Blood. 2010. Vol. 116. P. 631639.182.Kozeli fV, Epidemiology of f orofacial cleft in Slovenia, f 1973-1993:comparison of the f incidence in six Europian countries / V.Kozeli // JCraniomaxillofac Surg. 1996. – Vol. f 24, №6 – P. 378-382.183.KropfJ,JOSchurek,AWollner,andAMGressner.Immunologicalmeasurement of transforming growth factor-beta I (TGF-β1)inblood;assaydevelopmentandcomparison.ClincalChemistry1997:43(10):1965-1974.184.Lench I. The geographical f distibution of neural tube fdefects and oralcleft/I.Lench//Br.Med.
fBull.-1984-Vol.40, №4.-P.390-395.185.Lenz O., Elliot S.J. Stetler-Stevenson W.G. Matrix metalloproteinases inrenal development and disease. J Am Soc Nephrol 2000; 11: 574-581.186.Letra A, Silva RM, Motta LG, Blanton SH, Hecht JT, Granjeirol JM, et al.Association of ММП3 and ТИМП2 protomer polymorphisms with nonsyndromicoral clefts. Birth Defects Res A Clin Mol Teratol 2012; 94:540-48.187.Levy D. fPrevalence and clinical features fof mitral valve prolapse f / D.Levy, D.
f Savege // Am. Heart J. – 1987. – Vol 113. – P. 1281-1290.188.Li J., Scwimmbeck P.L., Tschope C. et al Collagen f degradation in amurine myocarditis f model: relevance of matri fx metalloproteinase inassociation fwith inflammatory induction. Cardiovase. Res. 2002; 56(2): 235-247.189.Li Z., Ren A., Liu J., Zhang L., Ye R., Li S., Li Z. High prevalence oforofacial clefts in Shanxi Province in northern China, 2004-2004.// Am. J. Med.Genet. – 2008/ - Oct. - 146A (20): - P. 2673-2643.190.Loffredo fL. Cleft lip and palate: fcase-control study / L. Loffredo, J. deSouza, f J. Yunes // Revista de Saude Publica. 1994.
fVol. 28, №3, P. 213-217.191.Lohmander – Agerskov A. Longitidual study of speech fin 15 children withcleft lip and fpalate treated by late f repair of the palate / A. Lohmander –107Agerskov, E. Soderpalm, H. Friede, J.A. Lilija // Scand. f J. Plast. Reconstr.fSurg.
Hand. f Surg – 1995. – Vol. 29. – N1. – P. 21-31.192.Lui M.L., Reilly M.P., Cassanto P. et al. Cholesterol enrichment of humanmonocyte/macrophages induces surface exposure of phosphatidylserine and therelase of biologikally-active tissue factor-positive microvesicles. Arterios. Throm.Vascul. Biol. 2007; 27(2): 430-435.193.Lynch H. Genetic couseling in cleft lip f and cleft palate / H. Lynch, W. fKimberlink // f Plast.
Reconstr. Surg. – 1981. – Vol. 11. – P. 800-815.194.Marlin-Neto f J. Funacao ventricular f no prolapse de valve mitral: efetosdo f bloqueto beta-adrenergico f com e sem atividate simpatomimetica intrinseca/ J. Marlin – Neto, L. matter – Junior, B. Macice // Arg. Bra. Cardiol. 1989.
Vol.52. P. 247-252.195.Meng L, Bian Z, Torensma R, Von den Hoff JW. Biological Mechanismsin Palatogenesis and Cleft Palate. J Dent Res 2009; 88:22–33.196.Milan f M. 766 cases of oral cleft in fItaly. Data from Emilia Romagna(IMER) and f northerst Italy (NEI) registers f / M. Milan, G. Astolfi, S. Volpato//European Journal of fEpidemiology.
– 1994. – Vol. 10, N 3. – P. 317 – 324.197.Milerad J. Associated fmalformations in infant with f cleft lip and palate: aprospective f, population-based study / J. Milerad // pediatrics. – 1997. – Vol.100, №2. – P. 180-186.)198.Murphy f G., Willenbrock F., Crabbe T. f et al. Regulation of matrixfmetalloproteinase activity. Ann.
NY Acad. Sci. 1994; 732: 31-41.199.Murphy G. Nagase H. Progress in matrix metalloproteinase research.Molecular Aspects of Medicine. 2008; 29: 290-308.200.Nagase H. Matrix matalloproteinases in Zinc Matalloproteinases in Healthand Disease (Hooper N.M., Taylor & Fracis, London, UK, 1996; 153-204.201.Nagase f H. Activation mechanisms f of matrix metalloproteinases.
Biol.fChem. 1997; 378(3-4): 151-160.108202.Nagase H., Woesner J.F. Matrix matalloproteinases. J Biol Chem. 1999;274(31):21491-21494) Nagase H., Woesner J.F. Matrix matalloproteinases. J BiolChem. 1999; 274(31):21491-21494.203.Negi P. Arrhythmias and f conduction defects in patients with fmitral valvefprolapse: a study based f on ambulatory monitoring f and electrophysiology fstudies / P. Negi, U. Kaul, V. Dev // J. Ass Physicians (India). – 1992. – Vol. 20.– P.
367 – 370.204.Nevin fN. Cleft lip and palate f hypertelorism, brachycephaly, flat facialprofile, and congenital f heart disease in three brothers f / N. Nevin // Am. J. MedGenet. 1997. Vol. 73, №4. P. 412 – 415.205.Nikopensius T, Kempa I, Ambrozaitytė L et al. Variation in FGF1,FOXE1, and ТИМП2 genes is associated with nonsyndromic fcleft lip with orwithout fcleft palate.
Birth Defects Res A Clin Mol Teratol. 2011; 91(4):218-25.206.Oliver f R. Neonatal feeding of infants fborn with cleft lip and/or palate:parental perception f of their experience in fsouth Wales / R. Oliver, G. Jones //Cleft Palate-Craniofacial f Journal. – 1997. – Vol. 34 № 6. – P. 526-532.207.Orgel fJ.P., Irving T.C., Miller f A. et al. Microfibrillar structure of type Icollagen f in situ. Proc. fNatl. Acad. Sci. 2006.
103(24):9001-5.208.Pei D., Weiss S.J. Furin-dependent intracellular activation f of the humanstromelysin-3 f zymogen. Nature 1995; 375(6528): 244-247.209.Pino M, Galleguillos C, Torres M, Sovino H, Fuentes A, Boric MA,Johnson MC. Associations between f ММП1 and ММП9 activities f and ICAM1cleavage induced by tumor f necrosis factor f eutopic endometria f of womenwith endometriosis f / M/ Pino [et al.] // Reproduction/ 2009/ - Vol. 138, №5.P.837- 847.210.Puljiz I., Markotić A., Cvetko Krajinović L.,., Gužvinec M, Polašek O.,Kuzman I. Mycoplasma pneumonia in adult fcommunity-acquired pneumoniafincreases matrix f metalloproteinase-9 serum level f and induces its geneexpression in peripheral f blood mononuclear cells / Ivan Puljiz, Alemka109Markotić, Lidija Cvetko, Marija Gužvinec, Ozren Polašek, Ilija Kuzman // MedSci Monit.
– 2012 – Vol. 18, №8. P. – 500-505.211.Qiu Z., Strickland D.K., Hyman B.T. et al. Alpha2-macroglobulin enhancesthe clearance of endogenous soluble beta-amyloid peptide via low-densitylipoprotein receptor-related protein in cortical neurons. J. Neurochem. 1999;73(4), 1393-1398.212.Qu C.J., f Rieppo J., Hyttinen M.M. et al f Humman articular cartilageproteoglycans f are not under sulfated in osteoarthritis f. Connect. Tiss. Res.2007; 48(1):27-33.213.Ramnath N. Matrix metalloproteinases finhibitors.
/ Ramnath, N., Creaven,P.J. // Cuur Oncol. – 2004. - №6. – P. 96-102.f214.Ridker fP.M., Buring J.E., Cook N.R. et al. C-reactive f protein, themetabolic syndrome, and risk of incident f cardiovascular events: an 8-yearfollow-up of 14,719 initially healthy American women. Circulation2003;107(3):391-397.215.Ronday H.K., Van der Laan W.H., Tak P.P. et al. Human granzyne Bmediates Cartilage proteoglycan degradation and is expressed at the invasivefront of the synovium in rheumatoid arthritis.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
